ROS-dependent antiproliferative effect of brassinin derivative homobrassinin in human colorectal cancer Caco2 cells

Molecules

Volumn 19, Issue 8, 2014, Pages 10877-10897

  Kello, Martin ^a   Drutovic, David ^a   Chripkova, Martina ^a   Pilatova, Martina ^a   Budovska, Mariana ^a   Kulikova, Lucia ^a   Urdzik, Peter ^a,b   Mojzis, Jan ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

Author keywords

Antiproliferative; Apoptosis; Homobrassinin; Indole phytoalexins; ROS

Indexed keywords

ANTINEOPLASTIC AGENT; BRASSININ; CASPASE 3; INDOLE DERIVATIVE; REACTIVE OXYGEN METABOLITE; THIOCARBAMIC ACID DERIVATIVE; TUBULIN;

APOPTOSIS; CACO 2 CELL LINE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; COLORECTAL TUMOR; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IC50; METABOLISM; MITOCHONDRION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CACO-2 CELLS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDOLES; INHIBITORY CONCENTRATION 50; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; THIOCARBAMATES; TUBULIN;

EID: 84906674652     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190810877     Document Type: Article

References (58)

1. Han, B.; Li, X.; Yu, T. Cruciferous vegetables consumption and the risk of ovarian cancer: A meta-analysis of observational studies. Diagn. Pathol. 2014, 9, 1-7.
2. Tse, G.; Eslick, G.D. Cruciferous vegetables and risk of colorectal neoplasms: A systematic review and meta-analysis. Nutr. Cancer 2014, 66, 128-139.
3. Liu, B.; Mao, Q.; Wang, X.; Zhou, F.; Luo, J.; Wang, C.; Lin, Y.; Zheng, X.; Xie, L. Cruciferous vegetables consumption and risk of renal cell carcinoma: A meta-analysis. Nutr. Cancer 2013, 65, 668-676.
4. Aras, U.; Gandhi, Y.A.; Masso-Welch, P.A.; Morris, M.E. Chemopreventive and anti-angiogenic effects of dietary phenethyl isothiocyanate in an N-methyl nitrosourea-induced breast cancer animal model. Biopharm. Drug Dispos. 2013, 34, 98-106.
5. Abdull Razis, A.F.; Noor, N.M. Cruciferous vegetables: Dietary phytochemicals for cancer prevention. Asian Pac. J. Cancer Prev. 2013, 14, 1565-1570.
6. Izutani, Y.; Yogosawa, S.; Sowa, Y.; Sakai, T. Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signalling pathway in human colon cancer cells. Int. J. Oncol 2012, 40, 816-824.
7. Kim, S.M.; Park, J.H.; Kim, K.D.; Nam, D.; Shim, B.S.; Kim, S.H.; Ahn, K.S.; Choi, S.H. Brassinin induces apoptosis in PC-3 human prostate cancer cells through the suppression of PI3K/Akt/mTOR/S6K1 signalling cascades. Phytother. Res. 2014, 28, 423-431.
8. Smith, B.; Randle, D.; Mezencev, R.; Thomas, L.; Hinton, C.; Odero-Marah, V. Camalexin-induced apoptosis in prostate cancer cells involves alterations of expression and activity of lysosomal protease cathepsind. Molecules 2014, 19, 3988-4005.
9. Pedras, M.S.; Yaya, E.E.; Glawischnig, E. The phytoalexins from cultivated and wild crucifers: Chemistry and biology. Nat. Prod. Rep. 2011, 28, 1381-1405.
10. Jeandet, P.; Clement, C.; Courot, E.; Cordelier, S. Modulation of phytoalexin biosynthesis in engineered plants for disease resistance. Int. J. Mol. Sci. 2013, 14, 14136-14170.
11. Borriello, A.; Bencivenga, D.; Caldarelli, I.; Tramontano, A.; Borgia, A.; Zappia, V.; Della Ragione, F. Resveratrol: From basic studies to bedside. Cancer Treat. Res. 2014, 159, 167-184.
12. Kim, H.J.; Lim, J.S.; Kim, W.K.; Kim, J.S. Soyabean glyceollins: Biological effects and relevance to human health. Proc. Nutr. Soc. 2012, 71, 166-174.
13. Moody, C.J.; Roffey, J.R.; Stephens, M.A.; Stratford, I.J. Synthesis and cytotoxic activity of indolyl thiazoles. Anticancer Drugs 1997, 8, 489-499.
14. 1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 2013, 8, e70627.
15. Romagnolo, D.F.; Davis, C.D.; Milner, J.A. Phytoalexins in cancer prevention. Front. Biosci. 2012, 17, 2035-2058.
16. Yin, H.T.; Tian, Q.Z.; Guan, L.; Zhou, Y.; Huang, X.E.; Zhang, H. In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac. J. Cancer Prev. 2013, 14, 1703-1706.
17. Mezencev, R.; Mojzis, J.; Pilatova, M.; Kutschy, P. Antiproliferative and cancer chemopreventive activity of phytoalexins: Focus on indole phytoalexins from crucifers. Neoplasma 2003, 50, 239-245.
18. Curillova, Z.; Kutschy, P.; Solcaniova, E.; Pilatova, M.; Mojzis, J.; Kovacik, V. Synthesis and antiproliferative activity of 1-methoxy-, 1-(α-D-ribofuranosyl)- and 1-(β-D-ribofuranosyl)brassenin B. ARKIVOC 2008, 8, 85-104.
19. Mezencev, R.; Kutschy, P.; Salayova, A.; Curillova, Z.; Mojzis, J.; Pilatova, M.; McDonald, J. Anticancer properties of 2-piperidyl analogues of the natural indole phytoalexin 1-methoxyspirobrassinol. Chemotherapy 2008, 54, 372-378.
20. Kutschy, P.; Salayova, A.; Curillova, Z.; Kozar, T.; Mezencev, R.; Mojzis, J.; Pilatova, M.; Balentova, E.; Pazdera, P.; Sabol, M.; et al. 2-(Substituted phenyl)amino analogs of 1-methoxyspirobrassinol methyl ether: synthesis and anticancer activity. Bioorg. Med. Chem. 2009, 17, 3698-3712.
21. Pilatova, M.; Ivanova, L.; Kutschy, P.; Varinska, L.; Saxunova, L.; Repovska, M.; Sarissky, M.; Seliga, R.; Mirossay, L.; Mojzis, J. In vitro toxicity of camalexin derivatives in human cancer and non-cancer cells. Toxicol. In Vitro 2013, 27, 939-944.
22. Takasugi, M.; Katsui, N.; Shirata, A. Isolation of 3 novel sulfur-containing phytoalexins from the Chinese-cabbage brassica-campestris L ssp pekinensis (cruciferae). J. Chem Soc. Chem Commun. 1986, 14, 1077-1078.
23. Mehta, R.G.; Liu, J.; Constantinou, A.; Thomas, C.F.; Hawthorne, M.; You, M.; Gerhuser, C.; Pezzuto, J.M.; Moon, R.C.; Moriarty, R.M. Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage. Carcinogenesis 1995, 16, 399-404.
24. Csomos, P.; Zupko, I.; Rethy, B.; Fodor, L.; Falkay, G.; Bernath, G. Isobrassinin and its analogues: Novel types of antiproliferative agents. Bioorg. Med. Chem. Lett. 2006, 16, 6273-6276.
25. Pilatova, M.; Sarissky, M.; Kutschy, P.; Mirossay, A.; Mezencev, R.; Curillova, Z.; Suchy, M.; Monde, K.; Mirossay, L.; Mojzis, J. Cruciferous phytoalexins: Antiproliferative effects in T-Jurkat leukemic cells. Leuk. Res. 2005, 29, 415-421.
26. Monde, K.; Taniguchi, T.; Miura, N.; Kutschy, P.; Curillova, Z.; Pilatova, M.; Mojzis, J. Chiral cruciferous phytoalexins: Preparation, absolute configuration, and biological activity. Bioorg. Med. Chem. 2005, 13, 5206-5212.
27. Kutschy, P.; Sykora, A.; Curillova, Z.; Repovska, M.; Pilatova, M.; Mojzis, J.; Mezencev, R.; Pazdera, P.; Hromjakova, T. Glyoxyl analogs of indole phytoalexins: Synthesis and anticancer activity. Collect. Czech. Chem. C 2010, 75, 887-903.
28. Budovska, M.; Pilatova, M.; Varinska, L.; Mojzis, J.; Mezencev, R. The synthesis and anticancer activity of analogs of the indole phytoalexins brassinin, 1-methoxyspirobrassinol methyl ether and cyclobrassinin. Bioorg. Med. Chem. 2013, 21, 6623-6633.
29. Ocenas, P.; Tomasova, L.; Kutschy, P.; Pazdera, P.; Mojzis, J.; Pilatova, M. Spirocyclisation of phytoalexin 1-methoxybrassinin in the presence of Grignard reagents. Chem. Pap. 2013, 67, 631-642.
30. Chripkova, M.; Drutovic, D.; Pilatova, M.; Mikes, J.; Budovska, M.; Vaskova, J.; Brogginy, M.; Mirossay, L.; Mojzis, J. Brassinin and its derivatives as potential anticancer agents. Toxicol. In Vitro 2014, 28, 907-915.
31. Banerjee, T.; Duhadaway, J.B.; Gaspari, P.; Sutanto-Ward, E.; Munn, D.H.; Mellor, A.L.; Malachowski, W.P.; Prendergast, G.C.; Muller, A.J. A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase. Oncogene 2008, 27, 2851-2857.
32. Patel, P.B.; Thakkar, V.R. L-Carvone induces p53, caspase 3 mediated apoptosis and inhibits the migration of breast cancer cell lines. Nutr. Cancer 2014, 66, 453-462.
33. Zhao, B.; Li, X. Altholactone induces reactive oxygen species-mediated apoptosis in bladder cancer T24 cells through mitochondrial dysfunction, MAPK-p38 activation and Akt suppression. Oncol. Rep. 2014, 31, 2769-2775.
34. Mezencev, R.; Updegrove, T.; Kutschy, P.; Repovska, M.; McDonald, J.F. Camalexin induces apoptosis in T-leukemia Jurkat cells by increased concentration of reactive oxygen species and activation of caspase-8 and caspase-9. J. Nat. Med. 2011, 65, 488-499.
35. Smith, B.A.; Neal, C.L.; Chetram, M.; Vo, B.; Mezencev, R.; Hinton, C.; Odero-Marah, V.A. The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species. J. Nat. Med. 2013, 67, 607-618.
36. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010, 48, 749-762.
37. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin. 2011, 61, 69-90.
38. Long, X.; Fan, M.; Bigsby, R.M.; Nephew, K.P. Apigenin inhibits antiestrogen-resistant breast cancer cell growth through estrogen receptor-alpha-dependent and estrogen receptor-alpha-independent mechanisms. Mol. Cancer Ther. 2008, 7, 2096-2108.
39. ElAttar, T.M.; Virji, A.S. Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anticancer Drugs 1999, 10, 187-193.
40. Baron-Menguy, C.; Bocquet, A.; Guihot, A.L.; Chappard, D.; Amiot, M.J.; Andriantsitohaina, R.; Loufrani, L.; Henrion, D. Effects of red wine polyphenols on postischemic neovascularization model in rats: Low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007, 21, 3511-3521.
41. Choi, E.J.; Kim, G.H. Antiproliferative activity of daidzein and genistein may be related to ERalpha/c-erbB-2 expression in human breast cancer cells. Mol. Med. Rep. 2013, 7, 781-784.
42. Downing, K.H.; Nogales, E. Tubulin and microtubule structure. Curr. Opin. Cell. Biol. 1998, 10, 16-22.
43. Perez, E.A. Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance. Mol. Cancer Ther. 2009, 8, 2086-2095.
44. Jordan, M.A.; Wilson, L. Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 2004, 4, 253-265.
45. Kang, J.; Pervaiz, S. Mitochondria: Redox metabolism and dysfunction. Biochem. Res. Int. 2012, 2012, 896751.
46. Green, D.R., Apoptotic pathways: Ten minutes to dead. Cell 2005, 121, 671-674.
47. Erejuwa, O.O.; Sulaiman, S.A.; Wahab, M.S. Effects of honey and its mechanisms of action on the development and progression of cancer. Molecules 2014, 19, 2497-2522.
48. Villena, J.; Madrid, A.; Montenegro, I.; Werner, E.; Cuellar, M.; Espinoza, L. Diterpenylhydroquinones from natural ent-labdanes induce apoptosis through decreased mitochondrial membrane potential. Molecules 2013, 18, 5348-5359.
49. Yang, T.; Li, M.H.; Liu, J.; Huang, N.; Li, N.; Liu, S.N.; Liu, Y.; Zhang, T.; Zou, Q.; Li, H. Benzimidazole derivative, BMT-1, induces apoptosis in multiple myeloma cells via a mitochondrial-mediated pathway involving H+/K+-ATPase inhibition. Oncol. Rep. 2014, doi:10.3892/or.2014.3122.
50. Thangam, R.; Senthilkumar, D.; Suresh, V.; Sathuvan, M.; Sivasubramanian, S.; Pazhanichamy, K.; Gorlagunta, P.K.; Kannan, S.; Gunasekaran, P.; Rengasamy, R.; et al. Induction of ROS-dependent mitochondria-mediated intrinsic apoptosis in MDA-MB-231 cells by glycoprotein from codium decorticatum. J. Agric. Food Chem. 2014, 62, 3410-3421.
51. Duan, D.; Zhang, B.; Yao, J.; Liu, Y.; Fang, J. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells. Free Radic. Biol. Med. 2014, 70, 182-193.
52. Gaspari, P.; Banerjee, T.; Malachowski, W.P.; Muller, A.J.; Prendergast, G.C.; DuHadaway, J.; Bennett, S.; Donovan, A.M. Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. J. Med. Chem. 2006, 49, 684-692.
53. Kutschy, P.; Sabol, M.; Maruskova, R.; Curillova, Z.; Dzurilla, M.; Geci, I.; Alfoldi, J.; Kovacik, V. A linear synthesis of 1-(beta-D-glucopyranosyl) brassinin, -brassenin A, -brassenin B and 9-(beta-D-glucopyranosyl)- cyclobrassinin. Collect. Czech. Chem. Commun. 2004, 69, 850-866.
54. Budovska, M.; Kutschy, P.; Kozar, T.; Gondova, T.; Petrovaj, J. Synthesis of spiroindoline phytoalexin (S)-(-)-spirobrassinin and its unnatural (R)-(+)-enantiomer. Tetrahedron 2013, 69, 1092-1104.
55. Ivanova, L.; Varinska, L.; Pilatova, M.; Gal, P.; Solar, P.; Perjesi, P.; Smetana, K., Jr.; Ostro, A.; Mojzis, J. Cyclic chalcone analogue KRP6 as a potent modulator of cell proliferation: An in vitro study in HUVECs. Mol. Biol. Rep. 2013, 40, 4571-4580.
56. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 1983, 65, 55-63.
57. Limame, R.; Wouters, A.; Pauwels, B.; Fransen, E.; Peeters, M.; Lardon, F.; de Wever, O.; Pauwels, P. Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 2012, 7, e46536.
58. Ke, N.; Wang, X.; Xu, X.; Abassi, Y.A. The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol. Biol. 2011, 740, 33-43.